Bergamaschi, R., Capobianco , M. and Ravasio, R. (2024) “Budget impact analysis of natalizumab biosimilar on pharmaceutical expenditure for the treatment of relapsing-remitting multiple sclerosis in Italy”, AboutOpen, 11(1), pp. 48–56. doi: 10.33393/ao.2024.3078.